- (Source: fda.gov)
Silver Spring, Maryland—(ENEWSPF)—February 15, 2018
By: Tara Rabin
The U.S. Food and Drug Administration today permitted marketing of the first blood test to evaluate mild traumatic brain injury (mTBI), commonly referred to as concussion, in adults. The FDA reviewed and authorized for marketing the Banyan Brain Trauma Indicator in fewer than 6 months as part of its Breakthrough Devices Program.
Most patients with a suspected head injury are examined using a neurological…
